Effects of Prevena Therapy on Obese and or Diabetic Patients With Surgical Groin Sites



Status:Enrolling by invitation
Conditions:Obesity Weight Loss, Peripheral Vascular Disease, Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases, Endocrinology
Healthy:No
Age Range:18 - Any
Updated:4/21/2016
Start Date:April 2013
End Date:December 2016

Use our guide to learn which trials are right for you!

EFFECTS OF PREVENA THERAPY ON REDUCTION OF GROIN SURGICAL SITE INFECTIONS IN OBESE PATIENTS UNDERGOING VASCULAR SURGERY

The purpose of the study is to determine the effects of Prevena therapy on decreasing groin
surgical site infections in patients who are obese and /or diabetic having vascular surgery.

Patients who are obese and/or diabetic may have poor surgical healing and infection rates
higher. The PREVENA therapy will be used to evaluate possible reduction of infection rates
in this patient population

Inclusion Criteria:

- subjects over 18 years old

- obese (BMI > 30) and or diabetic

Exclusion Criteria:

- current infected surgical field, hemodialysis, immunosuppressive therapy, allergy to
adhesive, sensitivity to silver
We found this trial at
1
site
?
mi
from
Columbus, OH
Click here to add this to my saved trials